The Association of the British Pharmaceutical Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have published an updated Code of Practice for the pharmaceutical ...

Novo Nordisk has been suspended from the Association of the British Pharmaceutical Industry (ABPI) due to what the organisation describes as ‘serious breaches’ of its code of practice. The decision ...

Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements." The UK's system of disclosing payments from pharma ...

Sunovion Pharmaceuticals Europe, Bayer, Astellas UK, Astellas Europe and Menarini Pharma UK SRL have been named in adverts for breaching of the ABPI’s Code of Practice. Sunovion Pharmaceuticals Europe ...

Novo Nordisk’s two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for serious breaches of the ABPI Code of Practice has come to an end [1]. Novo Nordisk’s return to ...

The code covers the promotion of prescription medicines to health professionals and appropriate administrative staff. In addition, it sets the standard for the provision of information on medicines to ...

Investing.com -- After a two-year suspension due to serious breaches of the Association of the British Pharmaceutical (TADAWUL:2070) Industry (ABPI) Code of Practice, Novo Nordisk (NYSE:NVO) has been ...